News
Though nerves abound for funders and founders in the industry, money continues to flow into startups, sometimes in ...
Under the Inflation Reduction Act, medications with the same active ingredient will be treated as the same drug for price ...
Swedish investment company EQT plans to take Fujitec, the Japanese maker of elevators and escalators, private through a $2.7 billion tender offer. The world's biggest coffee chain is moving away from ...
The pharmaceutical giant cut its guidance and said U.S. sales of Ozempic grew more slowly.
Danish drugmaker Novo Nordisk's stock was down nearly 20% in premarket trading Tuesday morning after the company cut its ...
Shares of Hims & Hers, which has clashed with Novo Nordisk over its sales of compounded glucagon-like peptide inhibitors, rose slightly in the wake of the report, and have more than doubled in value ...
Explore more
Novo now expects 2025 sales growth of 8%-14% in local currencies, down from its previous 13-21% range. It also lowered its ...
Import duties on Chinese goods could surge to about 80% if the pause expires on Aug. 12. Plus: UnitedHealth Group said its ...
Parents want more warnings after a brain-eating amoeba killed their boy on a South Carolina lake Travis Kelce Jumps In to Break Up Fight Between Chiefs Teammates at Training Camp Browns Owner Clears ...
Novo Nordisk's new CEO, Maziar Mike Doustdar, faces challenges in reviving waning sales and shares in the weight-loss drug ...
Novo Nordisk selloff is an overreaction. With solid fundamentals, a strong drug pipeline & long-term upside, discover why ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results